Commit To Purchase Healthpeak Properties At $15, Earn 6.3% Annualized Using Options

An analysis of selling a Healthpeak Properties Inc (DOC) put option with a $15 strike price expiring in January 2026 highlights a 6.3% annualized rate of return for the put seller, contingent on the contract not being exercised. The article suggests that the investor will only benefit from the premium unless DOC shares fall 12.3% and the contract is exercised, resulting in a cost basis of $14.45 per share. The piece advises using historical volatility, calculated at 23% for DOC, and fundamental analysis to assess the risk-reward profile of this put-selling strategy.

Analysis

The article details a specific options strategy involving selling a January 2026 put option on Healthpeak Properties Inc. (DOC) with a $15 strike price. This strategy offers the put seller a 6.3% annualized rate of return, derived solely from the collected premium, contingent upon DOC's share price not declining more than 12.3% from its current $17.14, thus keeping the share price above the $15 strike and allowing the option to expire worthless. Should the shares decrease below $15 and the option be exercised, the seller would acquire DOC shares at an effective cost basis of $14.45 per share (the $15 strike less the $0.55 premium received), before accounting for broker commissions. The report underscores that this approach does not allow participation in DOC's potential upside beyond the premium unless shares are assigned. With Healthpeak Properties Inc.'s trailing twelve-month volatility calculated at 23%, the article advises prospective investors to integrate this volatility measure with thorough fundamental analysis to ascertain if the offered 6.3% annualized yield presents a favorable risk-reward balance.

Key Decisions for Investors

• Investors considering this specific put-selling strategy on Healthpeak Properties Inc. (DOC) should carefully assess if the 6.3% annualized yield adequately compensates for the obligation to purchase shares at an effective cost of $14.45 should the stock price fall below $15 by January 2026.
• Conducting thorough fundamental analysis on DOC is critical to gauge the likelihood of its share price maintaining levels above the strike, and to determine the attractiveness of acquiring the stock at the potential assignment price.
• Given DOC's 23% historical volatility, investors should be prepared for potential price fluctuations and recognize that this strategy primarily offers income generation while forgoing significant upside participation unless shares are ultimately assigned.